Tag: international econometrics and finance award

Avanidhar Subrahmanyam | Econometrics and Finance | Best Researcher Award

Published on by WSA Awards

Prof. Avanidhar Subrahmanyam | Econometrics and Finance | Best Researcher Award

UCLA | United States 

Prof. Avanidhar Subrahmanyam is a globally recognized scholar in finance whose work has significantly shaped contemporary understanding of market microstructure, asset pricing, liquidity dynamics, and behavioral influences in financial decision-making. With a prolific academic record of 122 research documents, more than 15,960 citations, and an h-index of 49, he ranks among the most influential voices in modern financial economics. His research has appeared in premier journals and is frequently referenced in policy discussions, regulatory modeling, and advanced financial analytics, underscoring the practical relevance and theoretical depth of his contributions. Prof. Subrahmanyam is particularly renowned for pioneering insights into how investor psychology, information asymmetries, and market frictions influence asset prices and trading behavior—work that has advanced both academic discourse and real-world market design. His expertise extends across empirical finance, econometric modeling, and interdisciplinary research intersecting economics, psychology, and data science. Throughout his career, he has actively collaborated with leading international researchers, contributing to multi-institutional and cross-disciplinary projects that enhance global understanding of financial markets. These collaborations have resulted in influential frameworks used by practitioners, central banks, investment institutions, and risk-management bodies. His scholarship has played a critical role in informing studies related to liquidity crises, high-frequency trading, behavioral anomalies, and investor welfare, providing valuable guidance to regulators and industry leaders seeking to design stable and transparent markets. Prof. Subrahmanyam’s work also carries strong societal impact, offering analytical foundations for improving market fairness, mitigating systemic risks, and strengthening the financial resilience of economies.

Profiles: Scopus | Google Scholar

Featuered Publications

Daniel, K., Hirshleifer, D., & Subrahmanyam, A. (1998). Investor psychology and security market under‐ and overreactions. The Journal of Finance, 53(6), 1839–1885.

Brennan, M. J., & Subrahmanyam, A. (1996). Market microstructure and asset pricing: On the compensation for illiquidity in stock returns. Journal of Financial Economics, 41(3), 441–464.

Chordia, T., Roll, R., & Subrahmanyam, A. (2000). Commonality in liquidity. Journal of Financial Economics, 56(1), 3–28.

Chordia, T., Roll, R., & Subrahmanyam, A. (2001). Market liquidity and trading activity. The Journal of Finance, 56(2), 501–530.

Brennan, M. J., Chordia, T., & Subrahmanyam, A. (1998). Alternative factor specifications, security characteristics, and the cross-section of expected stock returns. Journal of Financial Economics, 49(3), 345–373.

Rena Conti | Econometrics and Finance | Best Researcher Award

Published on by WSA Awards

Prof. Rena Conti | Econometrics and Finance | Best Researcher Award

Questrom School of Business, Boston University | United States

Professor Rena M. Conti is a distinguished scholar in health economics and public policy, renowned for her influential contributions to the economics of healthcare markets, pharmaceutical innovation, and drug pricing regulation. With 156 scholarly publications, over 4,890 citations, and an h-index of 31, she has established herself as a global authority in the intersection of healthcare policy, economic analysis, and market dynamics. Her research focuses on understanding the mechanisms driving biopharmaceutical pricing, access to essential medicines, and the sustainability of healthcare systems. Professor Conti’s work has been featured in leading international journals, including JAMA, Health Affairs, and Nature Biotechnology, where her empirical analyses have informed both academic discourse and practical policymaking. Her collaborations extend across academia, government, and industry, where she has worked with public health agencies, pharmaceutical firms, and think tanks to design evidence-based policies that promote innovation while ensuring patient affordability. A key aspect of her impact lies in her ability to bridge the gap between economic modeling and real-world policy implementation, offering pragmatic solutions for optimizing market efficiency and health outcomes. She has also been actively involved in mentoring young researchers and contributing to interdisciplinary initiatives that explore the ethical, economic, and regulatory dimensions of healthcare innovation. Her leadership in shaping policy frameworks related to biosimilars, value-based pricing, and healthcare equity has positioned her as a leading voice in advancing sustainable global health systems. Beyond academia, her work has contributed to public debates on balancing innovation incentives with affordability, influencing policymakers and industry leaders worldwide. Through her rigorous scholarship, collaborative outlook, and commitment to public health, Professor Conti continues to play a pivotal role in transforming the global conversation on healthcare economics, ensuring that economic research serves both scientific advancement and social equity.

Profile: Scopus | ORCID | Google Scholar

Featured Publications

Qato, D. M., Alexander, G. C., Conti, R. M., Johnson, M., Schumm, P., & Lindau, S. T. (2008). Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA, 300(24), 2867–2878.

Epstein, A. M., Ayanian, J. Z., Keogh, J. H., Noonan, S. J., Armistead, N., Cleary, P. D., … (et al.) (2000). Racial disparities in access to renal transplantation—clinically appropriate or due to underuse or overuse? New England Journal of Medicine, 343(21), 1537–1544.

Howard, D. H., Bach, P. B., Berndt, E. R., & Conti, R. M. (2015). Pricing in the market for anticancer drugs. Journal of Economic Perspectives, 29(1), 139–162.

Dorsey, E. R., Rabbani, A., Gallagher, S. A., Conti, R. M., & Alexander, G. C. (2010). Impact of FDA black box advisory on antipsychotic medication use. Archives of Internal Medicine, 170(1), 96–103.

Dusetzina, S. B., Higashi, A. S., Dorsey, E. R., Conti, R., Huskamp, H. A., Zhu, S., … (et al.) (2012). Impact of FDA drug risk communications on health care utilization and health behaviors: A systematic review. Medical Care, 50(6), 466–478.

Md. Rubel Islam | Econometrics and Finance | Best Researcher Award

Published on by WSA Awards

Dr. Md. Rubel Islam | Econometrics and Finance | Best Researcher Award

Bangladesh Bank (The Central Bank of Bangladesh), Bangladesh

Dr. Md. Rubel Islam is an accomplished economist and researcher whose work focuses on the intersections of monetary policy, remittances, development economics, and financial inclusion. His research explores the socioeconomic and political dimensions of remittance flows, examining their influence on poverty reduction, household welfare, governance, and democratic development in emerging economies. By combining advanced econometric techniques with empirical data, he provides deep insights into how financial systems and policy reforms can enhance economic stability and inclusive growth. His scholarly contributions, published in leading international journals such as Review of Development Economics, Hitotsubashi Journal of Economics, and Social System Studies, highlight his ability to translate complex economic theories into actionable policy recommendations. In addition to his work on remittances, Dr. Islam’s research extends to central banking, macroeconomic management, and digital finance, where he emphasizes the role of technology and innovation in strengthening financial systems. His analytical proficiency with statistical software such as STATA, E-Views, and R supports his data-driven approach to research, allowing him to contribute meaningfully to evidence-based policy formulation. Through his academic and professional endeavors, Dr. Islam continues to advance the discourse on sustainable economic development, governance, and financial resilience, positioning himself as a thought leader in applied economics and policy innovation.

Profiles: ORCID | Google Scholar

Featured Publications

  1. Islam, M. R., & Lee, K. K. (2025). Do foreign remittances fuel or fight against corruption? Evidence from developing countries. Review of Development Economics.

  2. Islam, M. R., & Lee, K. K. (2024). Dynamics of remittances on household well-being in Bangladesh: Does regional migration matter? 社会システム研究, 85.

  3. Islam, M. R., & Lee, K. K. (2023). Do foreign remittances promote democracy? A dynamic panel study of developing countries. Hitotsubashi Journal of Economics, 64(1), 59–85.

  4. Islam, M. R. (2021). The impact of foreign remittances on household income and poverty: Empirical evidence from Bangladesh. Asian Journal of International Studies, 57, 76.

  5. Rahman, A., Khatun, R., Hoque, M. R., Ashraf, S., Rahman, A., & Islam, M. R. (2020). An impact assessment study on special agricultural credit program at 4 percent concessional interest rate. Special Research Work (SRW) of Bangladesh Bank, 2001.

Dr. Md. Rubel Islam’s work bridges the gap between academic research and real-world economic policymaking by providing data-driven insights that enhance financial inclusion, governance, and monetary stability. His research on remittances and macroeconomic policy supports sustainable economic growth, empowering developing nations to build resilient financial systems and reduce poverty through innovative policy solutions.